ClinicalTrials HQ

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Recruiting · NCT07140016 · Registry updated 2026-09-23
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-09-23NCT07140016

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Global Development, Inc.43

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Emory Winship Cancer InstituteAtlantaUnited States29
Hackensack University Medical CenterHackensackUnited States308
OSF Health CarePeoriaUnited States1
Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer CenterFullertonUnited States1
Site ES34006MadridSpain2
Site ES34008MálagaSpain1
Site ES34011MadridSpain1
Site ES34017BarcelonaSpain1
Site FR33001VillejuifFrance2
Site FR33005ToulouseFrance1
Site FR33008Saint-HerblainFrance1
University of California - IrvineOrangeUnited States4
University of Michigan Health SystemsAnn ArborUnited States3
UT Southwestern Medical Center at DallasDallasUnited States5
Vail Health Hospital - Shaw Cancer CenterEdwardsUnited States1
Virginia Cancer Specialists PCFairfaxUnited States9
Washington University School of MedicineSt LouisUnited States895